Merck Co

Early Phase 1 Data from Merck’s Oncology Pipeli...

Merck sets up €20m fund for Israeli biotech cos...

Merck Offering Refunds to 340B Covered Entities...

FDA nixes Merck’s shot at getting Januvia cardi...

Merck-მა შვეიცარიული MoonLake-ის 3 მილიარდ დოლა...

By IPP Bureau | December 17, 2024

Rush to buy Merck’s COVID-19 pill risks leaving...

Merck Group - Wikipedia

Merck tops earnings estimates on strong demand ...

Merck Announces Acquisition of Alydia Health on...

Merck to Invest € 70 Million to Expand its Reag...

Merck beats on revenue boosted by Keytruda sale...

Head Of Data Governance (All Genders) | London ...

Collaborators | My WordPress

Merck just dashed the last remaining hopes for ...

Merck's Third-Quarter Earnings and Sales Top Fo...

Merck KGaA Shares Spike After FDA Approves Skin...

Merck discontinues some cancer drug development...

Merck | Home

Merck Extends 2 Million Euros Support to India ...

Three million recognition moments: How Merck re...

Sehr Merck würdig: Der neue Markenauftritt des ...

Is Merck a Buy After Covid-Treatment Report? Ch...

Merck gets positive EU CHMP opinions for Keytru...

Merck gets FDA Breakthrough Therapy designation...

Merck

Merck to spin off assets with $6.5B in sales; 4...

Merck Challenges U.S. Government’s New Powers t...

Merck & Co., Inc. (NYSE:MRK) Shares Sold by Fif...

Merck KGaA reports positive results for M7824, ...

German Merck bests US Merck in UK copyright tus...

Merck KGaA sees future for enpatoran in lupus s...

Merck Presents Results on Efficacy and Safety o...

Merck beats quarterly sales estimate

Merck In Profile: Family-Owned Giant With A Lon...